...U.K.) raised $24 million in a venture round from Lorin Johnson and other founders of Salix Pharmaceuticals Inc....

...Glumetza from Depomed Inc. (NASDAQ:DEPO, Menlo Park, Calif.) in the U.S. through its acquisition of Salix Pharmaceuticals Inc....

...conductance regulator (CFTR) and calcium-activated chloride channel . Napo Pharmaceuticals Inc. , San Francisco, Calif. Salix Pharmaceuticals Inc....

...Inc. (NASDAQ:OREX)/Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) FDA approves Contrave naltrexone/bupropion for obesity Pharming Group N.V. (Euronext:PHARM)/Salix Pharmaceuticals Inc....

...Pharming to treat acute attacks in adult and adolescent patients with hereditary angioedema (HAE). Partner Salix Pharmaceuticals Inc....

...race to get deals done. Indeed, the latest tax-inversion deal was announced last week, when Salix Pharmaceuticals Inc....
...Basel, Switzerland Parnell Pharmaceuticals Holdings Ltd. (NASDAQ:PARN), Alexandria, Australia Pfizer Inc. (NYSE:PFE), New York, N.Y. Salix Pharmaceuticals Inc....

...NASDAQ:PCYC) Imbruvica ibrutinib CLL and small lymphocytic leukemia (SLL) PDUFA date 10/7/14 Pharming Group N.V. (Euronext:PHARM)/Salix Pharmaceuticals Inc....

...plan to start Phase III testing of dupilumab to treat moderate to severe atopic dermatitis. Salix Pharmaceuticals Inc....

...to the subcutaneous formulation (see BioCentury, Feb. 14, 2011). Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), Tarrytown, N.Y. Salix Pharmaceuticals Inc....